16
Mar
Houthoff -
On 9 March 2018, the European Commission published its 8th monitoring report on pharmaceutical patent settlements. The monitoring process was launched in 2009 as a result of the pharmaceutical sector inquiry. The sector inquiry report indicated that settlement agreements that limit entry of generic medicines onto the market and include a value transfer from an originator company to one or more generic companies are an example of potentially anti-competitive agreements. Such agreements may have negative effects on consumers...